Previous 10 | Next 10 |
Alnylam Pharmaceuticals (NASDAQ:ALNY), Crispr Therapeutics (NASDAQ:CRSP), Karuna Therapeutics (NASDAQ:KRTX) and six other biopharma names are among potential M&A candidates for 2022, according to Goldman Sachs. The nine new names have been added to Goldman Sach's Healthcare Strategic Asse...
Outset Medical (NASDAQ:OM) is trading ~5.3% higher in the post-market after the company announced it received the FDA’s 510(k) clearance for a new sterilization method of the cartridge used in its Tablo Hemodialysis System. The U.S. regulatory clearance allows the company to ...
Cartridge manufacturing in the new location localizes production, reduces cost and mitigates future supply chain risks Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis, announced today t...
New Recognition Program Highlights Tech Breakthroughs That Promise to Define the Future of Their Industries Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the release of its inaugural Environmental, Social, and Governance (ESG) report highlighting ...
Image source: The Motley Fool. Outset Medical Inc (NASDAQ: OM) Q3 2021 Earnings Call Nov 3, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Outset Medical Inc (OM) Q3 2021 Earnings Call Transcript
The following slide deck was published by Outset Medical, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Outset Medical, Inc. 2021 Q3 - Results - Earnings Call Presentation
Outset Medical, Inc. (OM) Q3 2021 Earnings Conference Call November 03, 2021, 05:00 PM ET Company Participants Brian Johnston - VP, IR, Gilmartin Group LLC Leslie Trigg - President and CEO Nabeel Ahmed - CFO Conference Call Participants Bob Hopkins - Bank of America Danielle Antalffy - SVB Le...
Outset Medical (NASDAQ:OM): Q3 Non-GAAP EPS of -$0.59 beats by $0.10; GAAP EPS of -$0.65 beats by $0.16. Revenue of $26.3M (+91.1% Y/Y) beats by $1.03M. Press Release For further details see: Outset Medical EPS beats by $0.10, beats on revenue
2021 Revenue Guidance Range Elevated to $99 million to $101 million Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...